Funder
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. WHO classification of tumours editorial board. Who classification of tumours 5th Edition Thoracic Tumours. International Agency for Research on Cancer; 2021.
2. Travis WD, International Agency for Research on C. WHO classification of tumours of the lung, pleura, thymus and heart. International Agency for Research on Cancer; 2015.
3. Niho S, Kenmotsu H, Sekine I, et al. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study. J Thorac Oncol. 2013;8(7):980–4.
4. Derks JL, Hendriks LE, Buikhuisen WA, et al. Clinical features of large cell neuroendocrine carcinoma: a population-based overview. Eur Respir J. 2016;47(2):615–24.
5. Varlotto JM, Medford-Davis LN, Recht A, et al. Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas? J Thorac Oncol. 2011;6(6):1050–8.